299 related articles for article (PubMed ID: 8635005)
1. Ovarian cancer screening.
van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
[TBL] [Abstract][Full Text] [Related]
2. Transvaginal sonography as a screening method for the detection of early ovarian cancer.
DePriest PD; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1997 Jun; 65(3):408-14. PubMed ID: 9190966
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer screening in asymptomatic postmenopausal women.
DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.
Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ
Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
[TBL] [Abstract][Full Text] [Related]
7. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer screening.
van Nagell JR; DePriest PD; Gallion HH; Pavlik EJ
Cancer; 1993 Feb; 71(4 Suppl):1523-8. PubMed ID: 8431889
[TBL] [Abstract][Full Text] [Related]
9. [The role of transvaginal ultrasonography in the screening of ovarian tumors].
De Rosa G; Catalano D; Dell'Isola A; Sarnataro C; Cerrone M
Minerva Ginecol; 1997 Jun; 49(6):243-9. PubMed ID: 9289662
[TBL] [Abstract][Full Text] [Related]
10. Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened.
van Nagell JR; Higgins RV; Donaldson ES; Gallion HH; Powell DE; Pavlik EJ; Woods CH; Thompson EA
Cancer; 1990 Feb; 65(3):573-7. PubMed ID: 2404560
[TBL] [Abstract][Full Text] [Related]
11. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
[TBL] [Abstract][Full Text] [Related]
12. Bilateral oophorectomy in asymptomatic women over 50 years old selected by ovarian cancer screening.
Hayashi H; Yaginuma Y; Kitamura S; Saitou Y; Miyamoto T; Komori H; Wada K; Ishikawa M
Gynecol Obstet Invest; 1999; 47(1):58-64. PubMed ID: 9852393
[TBL] [Abstract][Full Text] [Related]
13. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
[TBL] [Abstract][Full Text] [Related]
16. Status of tumor markers in ovarian cancer screening.
Bast RC
J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
[TBL] [Abstract][Full Text] [Related]
17. Transvaginal sonography of postmenopausal ovaries with pathologic correlation.
Fleischer AC; McKee MS; Gordon AN; Page DL; Kepple DM; Worrell JA; Jones HW; Burnett LS; James AE
J Ultrasound Med; 1990 Nov; 9(11):637-44. PubMed ID: 2258995
[TBL] [Abstract][Full Text] [Related]
18. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
Czekierdowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
[TBL] [Abstract][Full Text] [Related]
19. Transvaginal sonography as a screening method for ovarian cancer.
Higgins RV; van Nagell JR; Donaldson ES; Gallion HH; Pavlik EJ; Endicott B; Woods CH
Gynecol Oncol; 1989 Sep; 34(3):402-6. PubMed ID: 2670695
[TBL] [Abstract][Full Text] [Related]
20. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
BJOG; 2014 Dec; 121 Suppl 7():35-9. PubMed ID: 25488086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
